CATALAYER NEWS
Travere Therapeutics announces leadership changes in R&D
Source: Investing.com · 2026-06-16
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
EquipmentShare prices $1.35 billion senior secured notes at 7.125%
2026-06-16
Oxbridge Re Holdings shareholders elect directors and approve key proposals
2026-06-16
Form 4 Hycroft Mining Holding Corporation For: 16 June
2026-06-16
Form 4 Gilead Sciences Inc For: 16 June
2026-06-16
Form 4 Amprius Technologies Inc For: 16 June
2026-06-16
RELATED MARKETS
Prediction Markets